RE:RE:RE:RE:RE:Background to Gilead's $21 Bln acquisition of Immunomedics Onc is not followed by a huge base.
so....when news comes out. For example the upcoming Dec 9th presentation, little happens.
Quickly that is.
countless times, I have seen Onc release news. Price goes down that day, only to recover leading into the expected outcome.
Will Dec 9th be another let down? Not likely.
major milestone?
amything is possible.
I still feel, there are a few more chips to fall, before end of year.
The NR for the triple neg cancer is extremely vague.
minium there will be a follow up, giving in po8nt form what the presentation is all about.
so far all we have is a title & description of trial.